Platelet Rich Fibrin as a Modulator of the Wound Healing Response in Smokers
Platelet Rich Fibrin as a Modulator of the Wound Healing Response in Smokers
Bone healing is affected by smoking, particularly healing of extraction sockets, showing deficiencies in vertical and horizontal bone dimensions compared to the healing of non-smokers. Several approaches have been made to stimulate.
Bone wound healing, including human autologous blood-derived fractions. One of these fractions is the leukocyte platelet-rich fibrin (L-PRF).
L-PRF has been evidenced as potentially beneficial in promoting bone defect filling in alveolar bone and socket preservation in non-smokers. However, scarce evidence is related to this beneficial effect in smokers.
This clinical trial aims to study and compare the in vivo effects of L-PRF during bone wound healing and regeneration in smokers.
The main question is:
Has the L-PRF a beneficial effect during alveolar ridge preservation in smokers? After consent, participants with tooth extraction indications and implant rehabilitation treatment will be enrolled. After randomization, participants will be assigned to an experimental group treated with L-PRF plugs and membranes or a control group (physiological healing).
Participants will receive two interventions:
Diagnosis and evaluation before interventions: Volunteer participants will be selected after a clinical and periapical radiographic examination to establish the need for tooth extraction. Laboratory tests, including a complete blood coagulation profile, will be required for all volunteers. Finally, a salivary cotinine test will ensure the smoker's condition.
Inclusion Criteria:
Smokers (at least five cigarettes/day) have had the habit for at least one year.
Exclusion Criteria:
cemartinezc@uandes.cl56987660640
Santiago, Santiago Metropolitan 7820436, Chile